ArticleMetabolites2022

Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease.

Émilie Gobeil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.